Five Emerging HealthTech Sub Sectors Private Equity Should Be Screening Now Before the Multiples Move

By the time a sub-sector has a Kearney report, the entry multiple has already moved. Here's what's crossing our desk now.
  
The macroeconomic landscape for European healthcare technology has undergone a structural transformation. The speculative capital deployment into unintegrated point solutions that characterised the zero-interest-rate era has given way to an environment focused on unit economics, real-world clinical evidence, regulatory defensibility and deep workflow integration. The European HealthTech market is projected to expand from $96.68 Billion in 2025 to over $222 Billion by 2030, representing a compound annual growth rate (CAGR) of 18.11%. This long-term expansion is driven by severe systemic pressures: acute clinical labor shortages, aging demographics and administrative burdens that consume nearly half of a clinician’s working day.
  
Within this landscape, proprietary deal sourcing requires looking beyond conventional Health IT categories. Private equity firms seeking outsized returns must identify sub-sectors before institutional consensus drives valuation expansion.
  
Nelson Advisors' deal flow screening highlights five frontier sub-sectors currently moving through middle-market deal desks that present immediate platform-building and growth capital deployment opportunities within the €25 Million to €250 Million Enterprise Value (EV) window.

Click here to read the full report https://www.healthcare.digital/single-post/five-emerging-healthtech-sub-sectors-private-equity-should-be-screening-now-before-the-multiples-mov